NCT04068805

Brief Summary

Participants will be randomly assigned to either a positive affect skills intervention or a psychoeducation control group and assessed with questionnaires before, during, and after the 8-week program, as well as at 3 months, 6 months, and 12 months after the end of the program.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14

participants targeted

Target at below P25 for not_applicable diabetes-mellitus-type-2

Timeline
Completed

Started Aug 2020

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 23, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 28, 2019

Completed
1 year until next milestone

Study Start

First participant enrolled

August 31, 2020

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2021

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 12, 2022

Completed
Last Updated

July 19, 2022

Status Verified

July 1, 2022

Enrollment Period

7 months

First QC Date

August 23, 2019

Last Update Submit

July 15, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in self-reported HbA1C level

    1-item self-reported measure of Hemoglobin A1C (HbA1C) level, "What was your most recent HbA1c level?"

    Baseline, 3 weeks post-intervention (day 83), 3 weeks after 3-month post intervention (day 173), 3 weeks after 6 month post intervention (day 263), and 12 months post intervention (day 416)

Secondary Outcomes (5)

  • Change in Depression symptoms [PHQ-9 questionnaire]

    Baseline, immediate post-intervention at 8 weeks, and at 3, 6, and 12 months post-intervention

  • Change in Diabetes Regimen Adherence

    From baseline up to 63 days, 7 days at 3 months post intervention (146-153), 7 days at 6 months post intervention (236-243), and 12 months post intervention (day 416-423)

  • Change in Perceived Stress [Perceived Stress Scale (PSS)]

    Baseline, immediate post-intervention at 8 weeks, and at 3, 6, and 12 months post-intervention

  • Change in diabetes self-care activities [Summary of Diabetes Self-Care Activities (SDSCA)]

    Baseline, immediate post-intervention at 8 weeks, and at 3, 6, and 12 months post-intervention

  • Change in positive affect [Patient-Reported Outcomes Measurement Information Systems - Positive Affect Subscale(PROMIS)]

    Baseline, immediate post-intervention at 8 weeks, and at 3, 6, and 12 months post-intervention

Study Arms (2)

Positive affect condition

ACTIVE COMPARATOR

Participants use Happify and have the option to use a diabetes-specific track that focuses on building skills for greater happiness, reducing stress, and coping better with diabetes. Users may access a wide variety of 4-week programs and use them in any way they desire for the entire study period.

Behavioral: Happify

Psychoeducation condition

SHAM COMPARATOR

Participants complete a series of quizzes and polls on Happify designed to engage them in thinking about well-being topics, but without giving any specific instructions for how to promote well-being. Participants gain access to 8 weeks worth of content, but may repeat the content as often as they like in the follow-up period.

Behavioral: Happify

Interventions

HappifyBEHAVIORAL

An online platform for conveying techniques from positive psychology, cognitive-behavioral therapy, and mindfulness-based stress reduction.

Positive affect conditionPsychoeducation condition

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults with Type 2 Diabetes
  • Elevated HbA1c levels (7 or greater)
  • No prior experience on the Happify platform (new user registration)
  • PHQ-8 score of 13 or higher
  • US resident
  • Under the care of a medical professional for the treatment of their diabetes
  • Be willing and able to obtain HbA1c every 3 months

You may not qualify if:

  • none

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Happify (an online platform -- study is entirely online)

New York, New York, 10012, United States

Location

Related Publications (1)

  • Boucher E, Moskowitz JT, Kackloudis GM, Stafford JL, Kwok I, Parks AC. Immediate and Long-Term Effects of an 8-Week Digital Mental Health Intervention on Adults With Poorly Managed Type 2 Diabetes: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2020 Aug 4;9(8):e18578. doi: 10.2196/18578.

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Eliane Boucher, PhD

    Happify Inc.

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Users are randomly assigned between arms after completing baseline assessment and stay in that arm for the duration of the study.
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 23, 2019

First Posted

August 28, 2019

Study Start

August 31, 2020

Primary Completion

April 1, 2021

Study Completion

July 12, 2022

Last Updated

July 19, 2022

Record last verified: 2022-07

Locations